Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OBJECTIVES: The liver X receptors (LXRs) and farnesoid X receptor (FXR) have been identified in human platelets. Ligands of these receptors have been shown to have nongenomic inhibitory effects on platelet activation by platelet agonists. This, however, seems contradictory with the platelet hyper-reactivity that is associated with several pathological conditions that are associated with increased circulating levels of molecules that are LXR and FXR ligands, such as hyperlipidemia, type 2 diabetes mellitus, and obesity. APPROACH AND RESULTS: We, therefore, investigated whether ligands for the LXR and FXR receptors were capable of priming platelets to the activated state without stimulation by platelet agonists. Treatment of platelets with ligands for LXR and FXR converted platelets to the procoagulant state, with increases in phosphatidylserine exposure, platelet swelling, reduced membrane integrity, depolarization of the mitochondrial membrane, and microparticle release observed. Additionally, platelets also displayed features associated with coated platelets such as P-selectin exposure, fibrinogen binding, fibrin generation that is supported by increased serine protease activity, and inhibition of integrin αIIbβ3. LXR and FXR ligand-induced formation of coated platelets was found to be dependent on both reactive oxygen species and intracellular calcium mobilization, and for FXR ligands, this process was found to be dependent on cyclophilin D. CONCLUSIONS: We conclude that treatment with LXR and FXR ligands initiates coated platelet formation, which is thought to support coagulation but results in desensitization to platelet stimuli through inhibition of αIIbβ3 consistent with their ability to inhibit platelet function and stable thrombus formation in vivo.

Original publication

DOI

10.1161/ATVBAHA.117.309135

Type

Journal article

Journal

Arterioscler Thromb Vasc Biol

Publication Date

08/2017

Volume

37

Pages

1482 - 1493

Keywords

bile, blood coagulation, blood platelets, calcium, cholesterol, Benzoates, Benzylamines, Blood Coagulation, Blood Platelets, Calcium Signaling, Cell-Derived Microparticles, Cyclophilins, Dose-Response Relationship, Drug, Fibrin, Fibrinogen, Humans, Isoxazoles, Ligands, Liver X Receptors, Membrane Potential, Mitochondrial, P-Selectin, Phosphatidylserines, Platelet Activation, Platelet Aggregation Inhibitors, Platelet Glycoprotein GPIIb-IIIa Complex, Reactive Oxygen Species, Receptors, Cytoplasmic and Nuclear